Compliance Statements

Compliance & Regulatory Commitment
 

Affinity Bio Partners is committed to maintaining high standards of:
 

• ethics

• integrity

• scientific rigor

• patient advocacy

• quality

• and regulatory compliance
   

Our services are designed to support organizations operating within highly regulated healthcare, biotechnology, pharmaceutical, medical device, and clinical research environments.
 

Regulatory Alignment
 

Affinity Bio Partners supports programs and operations in alignment with applicable industry standards and regulatory frameworks, including where applicable:
 

• FDA regulations

• Good Clinical Practice (GCP)

• Good Manufacturing Practice (GMP)

• Good Laboratory Practice (GLP)

• ICH Guidelines

• HIPAA considerations

• pharmacovigilance standards

• quality management principles
   

Ethical Conduct
 

Affinity Bio Partners is committed to:
 

• ethical business practices

• scientific integrity

• patient-centered innovation

• transparency

• and operational excellence
   

No Guarantee of Regulatory Outcome
 

While Affinity Bio Partners provides strategic and operational support related to regulatory and clinical development activities, regulatory decisions remain solely within the authority of applicable governmental agencies and regulatory bodies.
 

Independent Professional Judgment
 

Clients, investigators, sponsors, healthcare providers, and regulatory authorities retain independent responsibility for:
 

• medical decision-making

• regulatory submissions

• clinical oversight

• legal compliance

• and patient care activities
   

Commitment to Innovation
 

Affinity Bio Partners supports responsible innovation in:
 

• biotechnology

• clinical research

• artificial intelligence

• digital health

• precision medicine

• patient advocacy

• and healthcare transformation
   

while maintaining focus on quality, compliance, patient safety, and scientific integrity.